-Note that afterload reduction is not as effective in HFpEF as it is in HFrEF There is no clearly effective chronic management, though aldosterone antagonists have shown promise, and ARNIs and SGLT2 inhibitors are currently being studied HFpEF is beginning to be viewed as more of a systemic/inflammatory condition, and may be treated as such in the future